IMRX
IMRX
NASDAQ · Biotechnology

Immuneering Corp - Class A

Penny Stocks Biotech Stocks Healthcare Stocks
$4.51
+0.05 (+1.12%)
As of Aug 8, 10:28 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -21.5% upside
Low Target $2.50
Average Target $3.54
High Target $3.55
Current Price $4.51
Current
$4.51
Target
$3.54
$2.50 $3.54 avg $3.55
Scenario Analysis
Bear Case
$2.50
-44.6%
Low target
Base Case
$3.54
-21.5%
Avg target
Bull Case
$3.55
+-21.3%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$10.08
-55.3% from high
52-Week Low
$2.90
+55.5% from low
Target vs 52W High
$3.54
-64.9% vs high
Next Earnings Report
Aug 12, 2026
2d
until earnings
EPS Est: $-0.27
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%